1
/
의
1
AntibodySystem
SKU(재고 관리 코드):KDH02201
Balstilimab ELISA Kit
Balstilimab ELISA Kit
Catalog No.: KDH02201
| Catalog No. | KDH02201 |
|---|---|
| Product name | Balstilimab ELISA Kit |
| Size | 96 T |
| Description | PRINCIPLE OF THE ASSAY This assay employs the quantitative competitive enzyme immunoassay technique. Recombinant Human CD279 has been pre-coated onto a microplate. Standards or samples are premixed with biotin-labeled antibody and then pipetted into the wells. Balstilimab in the sample competitively binds to the pre-coated protein with biotin-labeled Balstilimab. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in inversely proportion to the amount of Balstilimab bound in the initial step. The color development is stopped and the intensity of the color is measured. |
| Applications | Used for the quantitative determination of Balstilimab concentration in serum and plasma. |
| Stability and Storage | When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. |
| Detection method | Colorimetric |
| Precision | CV<20% |
| Sample type | Plasma, Serum |
| Assay type | Quantitative |
| Sensitivity | 24.35 ng/mL |
| Range | 62.5 - 4,000 ng/mL |
| Recovery | 80-120% |
| Background | Balstilimab is a novel, fully human monoclonal immunoglobulin G4 (IgG4) designed to block PD-1 (programmed cell death protein 1) from interacting with its ligands PD-L1 and PD-L2. PD-1 is a negative regulator of immune activation that is considered a foundational target within the immuno-oncology market. |
| Alternative Names | AGEN2034, CAS: 2230167-06-1 |
| Shipping | 2-8 ℃ |
| Note | For Research Use Only. |
Share
